Vertiv Holdings Co. (VRT)
268.87
+12.17
(+4.74%)
USD |
NYSE |
Sep 03, 16:00
268.74
-0.13
(-0.05%)
After-Hours: 20:00
Vertiv Holdings R&D to Revenue (TTM)
R&D to Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical R&D to Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -- |
| March 31, 2026 | -- |
| Date | Value |
|---|---|
| December 31, 2025 | -- |
R&D to Revenue Definition
The Research & Development (R&D) Expense to Revenue ratio measures the percentage of sales that is allocated to R&D expenditures. It is not as effective when looking at companies in different industries because different industries place different values on R&D. Technology companies and pharmaceutical companies are more likely to have high R&D ratios.
R&D to Revenue (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median